Transplacental exposure to the DNA demethylating agent, 5-AZA-CdR, affects the sexual behavior of CD-1 male mice

NeuroToxicology

Volumn 25, Issue 3, 2004, Pages 411-417

  Cisneros, Francisco J ^a   Branch, Stacy ^b  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

5 AZA 2 deoxycytidine (5 AZA CdR); Daily sperm production; Reproductive behavior; Reproductive toxicity; Sry gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CD1 ANTIGEN;

ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DEMETHYLATION; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENOTYPE; GESTATION PERIOD; MALE; MATING; MOUSE; NONHUMAN; PHENOTYPE; POSTNATAL GROWTH; PREGNANCY; PRIORITY JOURNAL; PROGENY; REDUCTION; REPRODUCTION; SEXUAL BEHAVIOR; SRY GENE;

ANIMALS; AZACITIDINE; DNA METHYLATION; FEMALE; MALE; MATERNAL-FETAL EXCHANGE; MICE; PREGNANCY; REACTION TIME; SEXUAL BEHAVIOR, ANIMAL;

EID: 1442312210     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2003.09.002     Document Type: Article

References (52)

1. Baker J., Hardy M.P., Zhou J., Bondy C., Lupu F., Bellve A.R., Efstratiadis A. Effects of an Igf1 gene null mutation on mouse reproduction. Mol. Endocrinol. 10:1996;903-918.
2. Bilsing A., Holub H., Nichelmann M. Sexual behavior of muscovy ducks under conditions of intensive husbandry of adult animals: dependence on the time of day, husbandry conditions, body mass and health status. Berliner und Munchener Tierarztliche Wochenschrift. 106:1993;55-59.
3. Birk O.S., Casiano D.E., Wassif C.A., Cogliati T., Zhao L., Zhao Y., Grinberg A., Huang S., Kreidberg J.A., Parker K.L., Porter F.D., Westphal H. The LIM homeobox gene Lhx9 is essential for mouse gonad formation. Nature. 403:2000;909-913.
4. Bishop C.E., Whitworth D.J., Qin Y., Agoulnik A.I., Agoulnik I.U., Harrison W.R., Behringer R.R., Overbeek P.A. A transgenic insertion upstream of sox9 is associated with dominant XX sex reversal in the mouse. Nat Genet. 26:2000;490-494.
5. Bovenzi V., Le N.L., Cote S., Sinnett D., Momparler L.F., Momparler R.L. DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2′-deoxycytidine. Anticancer Drugs. 10:1999;471-476.
6. Branch S., Chernoff N., Brownie C., Francis B.M. 5-AZA-2′- deoxycytidine-induced dysmorphogenesis in the rat. Teratog. Carcinog. Mutagen. 19:1999;329-338.
7. Branch S., Francis B.M., Brownie C.F., Chernoff N. Teratogenic effects of the demethylating agent 5-aza-2′-deoxycytidine in the Swiss Webster mouse. Toxicology. 112:1996;37-43.
8. Branch S., Francis B.M., Rosen M.B., Brownie C.F., Held G.A., Chernoff N. Differentially expressed genes associated with 5-Aza-2′-deoxycytidine- induced hindlimb defects in the Swiss Webster mouse. J. Biochem. Mol. Toxicol. 12:1998;135-141.
9. Branch S., Henry-Sam G. Altered hox gene expression and cellular pathogenesis of 5-aza-2′-deoxycytidine-induced murine hindlimb dysmorphogenesis. Toxicol. Pathol. 29:2001;501-506.
10. Branch S., Smoak I. The effects of 5-AZA-2′-deoxycytidine (d-AZA) on sonic hedghog expression in mouse embryonic limb buds. Toxic Substance Mechanisms. 19:2000;125-133.
11. Bulut H.E., Ozdemir O., Basimoglu-Koca Y., Korkmaz M., Atalay A. Effects of a DNA demethylating agent - 5-azacytidine - on testicular morphology during mouse embryo development. Okajimas. Folia. Anat. Jpn. 76:1999;47-53.
12. Chandrasekhar K., Raman R. De novo methylation of the proto-oncogene, c-fos, during development occurs step-wise and directionally in the laboratory mouse. Mol. Reprod. Dev. 48:1997;421-432.
13. Chubb C. (1993). Male mouse sexual behavior test. In Methods in toxicology (p. 16-25). New York: Academic Press Inc.
14. Cisneros F.J., Branch S. 5-AZA-2′-deoxycytidine (5-AZA-CdR): a demethylating agent affecting development and reproductive capacity. J. Appl. Toxicol. 23:2003;115-120.
15. Cisneros F.J., Wilson R., Travlos G., Anderson L.M., Branch S. Susceptibility to postnatal growth retardation induced by 5-AZA-2′- deoxycytidine in utero: gender specificity and correlation with reduced insulin-like growth factor 1. Life Sci. 72:2003;2887-2894.
16. Dasari V.K., Deng D., Perinchery G., Yeh C.C., Dahiya R. DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer. J. Urol. 167:2002;335-338.
17. Dean W., Bowden L., Aitchison A., Klose J., Moore T., Meneses J.J., Reik W., Feil R. Altered imprinted gene methylation and expression in completely ES cell-derived mouse fetuses: association with aberrant phenotypes. Development. 125:1998;2273-2282.
18. Ewart-Toland A., Mounzih K., Qiu J., Chehab F.F. Effect of the genetic background on the reproduction of leptin-deficient obese mice. Endocrinology. 140:1999;732-738.
19. Gill T.J. Jr. Mechanisms of action of major-histocompatibility-complex- linked genes affecting reproduction. Am. J. Reprod. Immunol. 41:1999;23-33.
20. Goodfellow P.N., Camerino G. DAX-1, an "antitestis" gene. Exs. 91:2001;57-69.
21. Goodfellow P.N., Lovell-Badge R. SRY and sex determination in mammals. Ann. Rev. Genet. 27:1993;71-92.
22. Hamann A., Matthaei S. Regulation of energy balance by leptin. Exp. Clin. Endocrinol. Diabetes. 104:1996;293-300.
23. Isles A.R., Baum M.J., Ma D., Szeto A., Keverne E.B., Allen N.D. A possible role for imprinted genes in inbreeding avoidance and dispersal from the natal area in mice. Proc. R. Soc. London B Biol. Sci. 269:2002;665-670.
24. Jackson-Grusby L., Beard C., Possemato R., Tudor M., Fambrough D., Csankovszki G., Dausman J., Lee P., Wilson C., Lander E., Jaenisch R. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet. 27:2001;31-39.
25. Jackson-Laboratory (1996). Sex-determination involves more than the Y chromosome.
26. Kafri T., Ariel M., Brandeis M., Shemer R., Urven L., McCarrey J., Cedar H., Razin A. Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev. 6:1992;705-714.
27. Koopman P., Bullejos M., Bowles J. Regulation of male sexual development by Sry and Sox9. J. Exp. Zool. 290:2001;463-474.
28. Lambert J.F., Benoit B.O., Colvin G.A., Carlson J., Delville Y., Quesenberry P.J. Quick sex determination of mouse fetuses. J. Neurosci. Methods. 95:2000;127-132.
29. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 69:1992;915-926.
30. Marchetti B., Gallo F., Farinella Z., Romeo C., Morale M.C. Luteinizing hormone-releasing hormone (LHRH) receptors in the neuroendocrine-immune network. Biochemical bases and implications for reproductive physiopathology. Ann. NY Acad. Sci. 784:1996;209-236.
31. Marshall Graves J.A., Shetty S. Sex from W to Z: evolution of vertebrate sex chromosomes and sex determining genes. J. Exp. Zool. 290:2001;449-462.
32. Martin C.C., Laforest L., Akimenko M.A., Ekker M. A role for DNA methylation in gastrulation and somite patterning. Dev. Biol. 206:1999;189-205.
33. McElreavey K., Barbaux S., Ion A., Fellous M. The genetic basis of murine and human sex determination: a review. Heredity. 75:1995;599-611.
34. MCG (2000). MCG researches explore genetic puzzle of sex. Medical College of Georgia.
35. Melo K.F., Martin R.M., Costa E.M., Carvalho F.M., Jorge A.A., Arnhold I.J., Mendonca B.B. An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis. J. Clin. Endocrinol. Metab. 87:2002;2500-2505.
36. Mittwoch U. Genetics of sex determination: exceptions that prove the rule. Mol. Genet Metab. 71:2000;405-410.
37. Momparler R.L., Bovenzi V. DNA methylation and cancer. J. Cell Physiol. 183:2000;145-154.
38. Momparler R.L., Cote S., Eliopoulos N. Pharmacological approach for optimization of the dose schedule of 5-Aza-2′-deoxycytidine (Decitabine) for the therapy of leukemia. Leukemia. 11(Suppl. 1):1997;1-6.
39. Nelson R.J. The use of genetic "knockout" mice in behavioral endocrinology research. Horm. Behav. 31:1997;188-196.
40. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 99:1999;247-257.
41. Page, D. (2002). Germ cells and sex chromosomes in mammals.
42. Palanza P., Morellini F., Parmigiani S., vom Saal F.S. Prenatal exposure to endocrine disrupting chemicals: effects on behavioral development. Neurosci. Biobehav. Rev. 23:1999;1011-1027.
43. Raman R., Narayan G. 5-Aza deoxyCytidine-induced inhibition of differentiation of spermatogonia into spermatocytes in the mouse. Mol. Reprod. Dev. 42:1995;284-290.
44. Reik W., Dean W., Walter J. Epigenetic reprogramming in mammalian development. Science. 293:2001;1089-1093.
45. Riggs A.D. X inactivation, differentiation, and DNA methylation. Cytogenet. Cell Genet. 14:1975;9-25.
46. Rogers J.M., Francis B.M., Sulik K.K., Alles A.J., Massaro E.J., Zucker R.M., Elstein K.H., Rosen M.B., Chernoff N. Cell death and cell cycle perturbation in the developmental toxicity of the demethylating agent, 5-aza-2′-deoxycytidine. Teratology. 50:1994;332-339.
47. Rugh, R. (1994). The mouse: its reproduction and development. New York: Oxford University Press.
48. Salas-Cortes L., Jaubert F., Barbaux S., Nessmann C., Bono M.R., Fellous M., McElreavey K., Rosemblatt M. The human SRY protein is present in fetal and adult Sertoli cells and germ cells. Int. J. Dev. Biol. 43:1999;135-140.
49. Viger R.S., Mertineit C., Trasler J.M., Nemer M. Transcription factor GATA-4 is expressed in a sexually dimorphic pattern during mouse gonadal development and is a potent activator of the Mullerian inhibiting substance promoter. Development. 125:1998;2665-2675.
50. Vilain E. Genetics of sexual development. Ann. Rev. Sex. Res. 11:2000;1-25.
51. Vilain E., Le Fiblec B., Morichon-Delvallez N., Brauner R., Dommergues M., Dumez Y., Jaubert F., Boucekkine C., McElreavey K., Vekemans M.et al. SRY-negative XX fetus with complete male phenotype. Lancet. 343:1994;240-241.
52. Vilain E., McCabe E.R. Mammalian sex determination: from gonads to brain. Mol. Genet. Metab. 65:1998;74-84.